Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015 Now Available at iData Insights Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, Muscle Wasting Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Muscle Wasting Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Muscle Wasting Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease... Browse with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=161168/musclewasting-disorders-global-clinical-trials-review-h2-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=161168/muscle-wasting-disorders-global-clinical-trials-review-h2-2015 Table of Contents
Disorders to Musculoskeletal Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 1
Clinical Trials by E7 Countries: Proportion of Muscle Wasting Disorders to Musculoskeletal Clinical Trials 19 Clinical Trials by Phase in E7 Countries 20 Clinical Trials in E7 Countries by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Clinical Trials by End Point Status 25 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28 Top Companies Participating in Muscle Wasting Disorders Therapeutics Clinical Trials 29 Prominent Drugs 30 Latest Clinical Trials News on Muscle Wasting Disorders 31 Oct 05, 2015: Atara Bios PINTA 745 Improves Insulin Sensitivity and Alters Fat Metabolism in Mice Fed With a High Fat Diet 31 Aug 31, 2015: Atara Biotherapeutics Announces Completion of Enrollment in PINTA 745 Phase 2 Clinical Trial in End-Stage Renal Disease Patients With Protein Energy Wasting 31 Clinical Trial Profile Snapshots 32 Appendix 128 Abbreviations 128 Definitions 128 Research Methodology 129 Secondary Research 129 About GlobalData 130 Contact Us 130 Disclaimer 130 Source 131 Read More http://www.idatainsights.com/reports-landing-page.php?id=161168/muscle-wastingdisorders-global-clinical-trials-review-h2-2015 2
About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects
3
4